Live on App Store · Google Play
WhatsApp / iMessage (Nov)

The personalchief of staff forAutoimmunity.

For 820M people, autoimmunity flares with daily life, and managing it alone drains the energy they need to live. Today, Buddy turns their wearables, meals, cycle and environment into a science-backed daily plan. Soon, she handles the rest.

today — buddy plans your day
next — buddy handles the rest
BuddyRise daily check-in: Buddy reads your sleep, adapts your plan and logs your breakfastBuddyRise flare mode: one message activates a full plan — meals, calendar, messages, prescriptions and doctor notes
<90
Days
7000+
Patients
86% women
60,000
AI conversations
med. 10 min/session
12
Countries
$0
CAC
As featured in
ForbesDe TijdTrendsDe MorgenLa LibreHR MagazineLe SpécialisteMedi-SphereHet NieuwsbladHet Laatste NieuwsMediQualityThe Top VoicesNewsmonkey
00 — PRODUCT DEMO
0:00 / 0:00
01 — PROBLEM

Healthcare is episodic.Autoimmunity moves with daily life.

Environment & daily life (gut health, sleep, stress and hormones) can shape the disease every day. Doctors see ~4 snapshots a year. Patients carry the rest alone.

One patient · one year

Seen by a doctorOn their own
~4 days
with a doctor · ~1 hour of care
361 days
managing it alone

The science behind it

Immunity is shaped more by environment than genes.

Brodin et al. · Cell, 2015

Exposures can trigger autoimmunity: EBV raised MS risk 32-fold.

Bjornevik et al. · Science, 2022

Changing daily inputs can improve outcomes.

Levine et al. · Gastroenterology, 2019

See the full evidence base
02 — WHY BUDDY
Charline d’Oultremont

Bed-bound with MS at 24, I became my ownchief of staff & got my life back.

Charline D’oultremontCo-founder & CEO, BuddyRise

  1. Age 24

    I walked holding onto the walls.

    8 years of symptoms, diagnosed with MS at 24. Bed-bound for a year, unable to feel most of my body.

  2. Years alone

    Googling at midnight, in pain.

    Detective, researcher, nutritionist, chef and coach. A paid coach for 6 months, then alone again.

  3. Last 3 years

    I found my patterns.

    Stable for three full years, by matching my daily life to the science.

  4. Ahead

    A lifetime still to go.

    Hormones change. Life changes. The science changes. My plan has to keep up.

Fatigue is real. Decision fatigue is worse. I have 60 more years to go. 820 million of us need a chief of staff.This is happening.

03 — MARKET

I’m not Alone, 820 million othersdon’t know what their body will do next.

1 in 10

people live with autoimmunity

Conrad et al. · The Lancet, 2023

1 in 3 live with more than one condition
PMC3290803
>$100B a year in US costs alone
NIH estimate
~80% are women
NIH ORWH

One of the largest gaps in women’s health

80% are women and science still can’t explain why; 2 in 3 autoimmune trials still under-enroll women; 80% of drug studies in mice are done on males. Buddy is here to fill that gap.

Nearly 30% of pharmacy spend for self-insured US employers. · General Catalyst, 2025

04 — PRODUCT

No more apps to log. Just text or call.Buddy turns your patterns into a daily plan.

Autoimmune fatigue is real. Tracking is exhausting. Everything is fragmented. Buddy texts first.Send a voice note, a meal photo or a quick call. Get a science-backed plan, every day.

What patients juggle today

  • Research papers
  • Google searches
  • Symptom tracker
  • Food log
  • Cycle app
  • Wearable app
  • Notes for the doctor

Seven tools. Endless decisions. Zero connection.

Buddy WhatsApp conversation with Lydia, her daily plan, breakfast and personalized observation

What Buddy does

Checks-in by text.

Buddy connects your patterns & checks-in.

Logs it for you.

Text, voice or a photo. Symptoms, meals, cycle, meds, wearables.

Connects the dots.

Your patterns, matched to autoimmune research.

Decides with you.

One clear plan every morning. No guesswork.

Live on

App StoreGoogle PlayWhatsApp(premium Nov 2026)iMessage(Dec Launch)
05 — SOON

When your body says NO, Buddy acts.

Today she plans your day. Next, she handles it.

One message

WhatsApp chat with Buddy: she says she's having a flare and sends a voice note; Buddy replies 'On it'

What Buddy handles

MealsRecovery meals ordered with Hungryroot & DoorDash
WorkSick-day email to your boss, in drafts
FamilyNote to Mom ready · school pickup email in drafts
InsuranceReimbursement claim filled in, ready to sign
BenefitsFlexible-work request drafted for HR
PharmacyRefill requested
Doctor90-day report, ready to send
Today · Understands2027 · HandlesNext · Advocates with employers, insurers & pharma
06 — TRACTION

AI buddy launch, <90 days: +7000 patients, $0 CAC

In <90 days, patients talked to Buddy 2x as they’ll see their doctor all year.

60K+
Buddy Conversations
10 min
Median session
15,000
Symptoms logged
97
Autoimmune conditions logged
86%
Women patients
AI Buddy Launch & Week 1 Return
100% organic growth at $0 CAC
7k3.5k00%100%200%≈150% avg MoM growthJul 12Jul 26Aug 9Aug 23Sep 9Sep 23Oct 1512 countries5007,000+
Hover (or tap) a marker to see that week's Week-1 return rate
07 — DATA INFRASTRUCTURE

The first longitudinal record of autoimmune daily life.Linked to outcomes.

Everyone else sees a snapshot. Buddy sees the whole year.

Doctor
Clinic visits
~4 snapshots
Insurer
Claims
Billing only
Pharma
Trial visits
If enrolled
Wearables
Sleep, HRV, temperature
24/7
no autoimmune context
Buddy
Symptoms, meals, cycle + wearables
Every day
with context
JanAprJulOctDec
Network effect

Every patient teaches Buddy. What works and what doesn't, across daily life, biometrics and meals, feeds back into one real-world autoimmune trial that never stops.

Already in the record: 7,000+ patients · 60K+ conversations in <90 days.

08 — BUSINESS MODEL

A sequenced path to $100M+ ARR.

Consumer wedge. Continuous intelligence. Enterprise-scale value.

1 · PATIENTS · Q4 2026
$99/yr
7-day free trial → 1M paying by 2034
WhatsApp premium launching
2 · EMPLOYERS · NOW
$8 PEPM
250 companies like our first LOI
First LOI: 4,000 employees, $25K
3 · INSURERS · THEN
$60 PMPM
139K lives × $60/mo
Built on PROMIS outcomes already
4 · PHARMA & RESEARCH
$200/yr
per patient · 5 partners × 100K
300-patient lupus study, 2027

The app is the entry point. The intelligence layer is the business.

09 — GO-TO-MARKET

Organic pull today. Paid and enterprise next.

TODAY · IN <90 DAYS

Pull

7,000+
patients

10M+ views (+3M/month) · 33K followers · $0 spent

Via founder-led content

2027–29

Accelerate

1M
downloads · 50K paying · ~$5M ARRTarget

7,000+ patients, 100% organic · First paid tests: $0.17 per install · Target paid CAC <$60 vs ~$200 LTV ($99/yr)

Via creators, ambassadors, App Store, referrals

NOW → 2032

Distribute

1M+
covered livesTarget

One national insurer alone could bring millions of eligible members.

Via employers, insurers, care programs · first LOI signed

Patients trust a patient who’s done the impossible. Our founder, living with MS, is one.

10 — WHY NOW

AI, wearables and NIH finally caught up.

AI

A coach that understands you is now affordable.

AI can now make sense of one person’s data, at a cost that scales to millions.

Wearables

The body is finally tracked every day.

Sleep, HRV, temperature and cycle now come from everyday devices.

Institutions

NIH and employers are paying attention.

NIH launched its first autoimmune research plan (2026–2030). Autoimmune drives nearly 30% of employer pharmacy spend.

For the first time, continuous autoimmune intelligence is possible.

11 — COMPETITION

The market is proven. The next generation of autoimmune care is AI-native and real-time.

Diabetes built Livongo. Back pain built Hinge. Metabolic health built Omada. Mymee proved that tracking daily life in autoimmunity reveals what drives flares, and payers will pay for it.

Autoimmune care comparison
CompanyAutoimmune-specificAI-firstScales without coaches
WellTheoryHuman coaches, sold to employers & payers · $26M raisedYesNoNo
JunoAI assistant for chronic illness in general · YC ’26NoYesYes
BuddyAI chief of staff for autoimmunity · 7,000+ patients, $0 spentYesYesYes

$35M+ invested in these three proves the need. Only Buddy is AI-first and built for autoimmunity.

12 — WHY US?

Lived experience. Technical execution. Clinical authority.

We spoke to 500 patients & 200 practitioners for a year before writing a single line of code on Buddy and going full in.

Charline d'Oultremont
Charline d'Oultremont
Co-founder & CEO

Living with MS: from bed-bound to walking again. 5 years in AI ethics & governance at UNESCO, the EU Commission, MILA and FARI. Grew BuddyRise to 7,000+ users and 10M+ views, $0 spent.

Celeste Cockmartin
Celeste Cockmartin
Co-founder & CTO

Full-stack developer & neuroscientist (King's College London, UN). Built and shipped BuddyRise's app, AI engine and data infrastructure.

Dr. Katrien de Vusser
Dr. Katrien de Vusser
Medical Advisor & Clinical Pilot Lead

Principal Investigator on BuddyRise's clinical research. Trained at Cleveland Clinic and Harvard Medical School. Board member, ERN ReCONNET, Europe's lupus reference network.

Trusted backgrounds, proven impact: UNESCO, European Commission, Mila, FARI, King's College London, United Nations, Cleveland Clinic, Harvard Medical School, Thrive85
13 — THE ASK
Raising
$2.5M
Round
Pre-seed
Closing
Q4 2026
RDY.VC (Pre launch)
$50K closed · $50K committed

What this round proves.

What the pre-seed round proves in 24 months
ProofTodayIn 24 monthsHow
Patients payPremium launching50K paying · ~$5M ARRHard paywall, 7-day trial, growth on a $0-CAC engine
Employers buy1 LOI · 4,000 employees3–5 contractsTurn the first pilot into repeatable sales
Outcomes are realUniversity hospital partnership2 clinical studiesThe evidence insurers and pharma pay for
Use of funds
55% Team · AI, engineering, sales25% Growth · creators, ambassadors, paid20% Product, research & ops
14 — Contact

820 million people need their energy back.Let’s build their chief of staff for every stop of this lifelong journey.

7,000+
patients in <90 days
$0
spent on acquisition
$2.5M
pre-seed · closing Q4
Charline d’Oultremont
“I lost my ability to walk at 24. I’m building what I need for the next 50 years ahead. This is happening. The only question is: do you want in?”

Charline d’Oultremont, Co-founder & CEO · living with MS